Excel Industries Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 25 May 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.3K Cr
FY '25 revenue grew 18% YoY to approx. Excel Industries targets EBITDA margins of 13% to 15% over the medium term, aiming for a resilient and sustainable business model with operational efficiencies and improved product mix.
From Excel Industries Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,089
Market Cap
₹1.3K Cr
P/E Ratio
17.9
How does Excel Industries Ltd rank in Chemicals & Petrochemicals?
Compare Excel Industries Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.
Excel Industries Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹281 Cr, net profit ₹12 Cr.
Full financials →📊 Revenue & Sales Performance
- →FY '25 revenue grew 18% YoY to approx. Rs 978 crores, driven largely by volume growth with some price benefit.
- →Normal monsoon forecast for India in FY '26 expected to support a normal agrochemical sector year.
- →Biocides capacity expansion to be completed by H2 FY '26, potentially providing incremental revenue.
- →Focus on both spot market and strategic product positioning over order book approach.
- →Plans to spend Rs 200-300 crores CAPEX over 3 years to support growth, including new product launches and capacity expansion.
- →Continued emphasis on specialty chemicals alongside agrochemicals to diversify revenue mix.
- →Aim to improve capacity utilization from current 70-75%, with peak possible at 85-90%.
- →Growth CAPEX expected to target specialty chemicals and adjacent product opportunities.
- →Anticipation of steady or improving EBITDA margins (13-15%) aligning with growth.
📈 Profitability & Margins
- →Excel Industries targets EBITDA margins of 13% to 15% over the medium term, aiming for a resilient and sustainable business model with operational efficiencies and improved product mix.
- →FY '25 saw an 18% revenue growth to Rs 978 crores and a strong EBITDA increase of 400%, indicating positive momentum.
- →Future CAPEX of Rs 200 to 300 crores over 3 years focuses on growth opportunities, especially in specialty chemicals and existing/adjacent products, supported by a strong balance sheet and internal accruals.
- →Capacity utilization currently at 70%-75%, with a peak effective utilization of 85%-90% before new CAPEX required, supporting scalable growth.
- →Volume growth is expected to drive revenue increases alongside new product launches, including biocides and contract manufacturing opportunities.
- →The company plans to maintain a balanced approach to growth with both maintenance and growth CAPEX for sustained profitability and earnings expansion.
🏗️ Capital Expenditure Plans
- →Excel Industries plans to spend Rs. 200 to Rs. 300 crores of CAPEX over the next 3 years covering maintenance, modernization, and growth initiatives.
- →Annual maintenance and modernization CAPEX is typically Rs. 40 to Rs. 50 crores.
- →Growth CAPEX will focus on both new product opportunities and strengthening existing product lines, with an emphasis on specialty chemicals.
- →Rs. 15 crores is allocated for setting up an R&D center for process development and technology innovation.
- →Asset turnover for future growth CAPEX is expected in the range of 1.25 to 1.5 times.
- →Internal accruals will largely support these investments, backed by a strong balance sheet.
- →Capacity expansions include doubling capacity for certain biocides and increasing agrochemical production capabilities.
💰 Fundraising & Capital Structure
- →No specific mention of new fundraising through debt or equity was made during the call.
- →The Company currently has a strong balance sheet.
- →Support for planned investments and CAPEX (Rs. 200-300 crores over 3 years) is planned to be largely funded through internal accruals.
- →No disclosure of new borrowings or equity issuance was indicated at this time.
- →Any future requirements or disclosures related to fundraising will be communicated as necessary.
📋 Order Book & Pipeline
- →Excel Industries does not follow a traditional order book approach; instead, they focus on a mix of spot market opportunities and positioning for key products.
- →The company sees good demand for certain biocides and has already expanded capacity in this segment.
- →They are working on a range of new biocide products to expand this portfolio.
- →The company anticipates a normal agrochemical sector year in FY '26, supported by forecasts of a normal monsoon in India.
- →Due to volatile market conditions, Excel prefers to maintain flexibility rather than relying on a fixed order book.
- →No specific disclosures were made about pending orders or order backlog, reflecting a focus on real-time market dynamics rather than long-term order commitments.
Key Metrics
Frequently Asked Questions
What were Excel Industries Ltd Q4 FY25 results?
FY '25 revenue grew 18% YoY to approx. Excel Industries targets EBITDA margins of 13% to 15% over the medium term, aiming for a resilient and sustainable business model with operational efficiencies and improved product mix.
What is Excel Industries Ltd share price analysis?
Excel Industries Ltd currently shows a neutral. The stock trades at a P/E of 17.9 with a market cap of ₹1,274 Cr. Investors should review the full earnings analysis for detailed insights.
Is Excel Industries Ltd planning capital expenditure?
Excel Industries plans to spend Rs.
Keep Excel Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.